Targeted Intervention to Improve the Quality of Head and Neck Radiation Therapy Treatment Planning in the Netherlands: Short and Long-Term Impact.


Journal

International journal of radiation oncology, biology, physics
ISSN: 1879-355X
Titre abrégé: Int J Radiat Oncol Biol Phys
Pays: United States
ID NLM: 7603616

Informations de publication

Date de publication:
01 11 2019
Historique:
received: 09 04 2019
revised: 20 06 2019
accepted: 04 07 2019
pubmed: 16 7 2019
medline: 31 1 2020
entrez: 16 7 2019
Statut: ppublish

Résumé

To benchmark and improve, through means of a targeted intervention, the quality of intensity modulated radiation therapy treatment planning for locally advanced head and neck cancer (HNC) in the Netherlands. The short and long-term impact of this intervention was assessed. A delineated computed tomography-scan of an oropharynx HNC case was sent to all 15 Dutch radiation therapy centers treating HNC. Aims for planning target volume and organ-at-risk (OAR) dosimetry were established by consensus. Each center generated a treatment plan. In a targeted intervention, OAR sparing of all plans was discussed, and centers with the best OAR sparing shared their planning strategies. Impact of the intervention was assessed by (1) short-term (half a year after intervention) replanning of the original case and (2) long-term (1 and 3 years after intervention) planning of new cases. Benchmarking revealed substantial difference in OAR doses. Initial mean doses were 22 Gy (range, 15-31 Gy), 35 Gy (18-49 Gy), and 37 Gy (20-46 Gy) for the contralateral parotid gland, contralateral submandibular gland, and combined swallowing structures, respectively. Replanning after targeted intervention significantly reduced mean doses and variation, but clinically relevant differences still remained: 18 Gy (14-22 Gy), 28 Gy (17-45 Gy), and 29 Gy (18-39 Gy), respectively. One and 3 years later the variation remained stable. Despite many years of HNC intensity modulated radiation therapy experience, initial treatment plans showed surprisingly large variations. The simple targeted intervention used in this analysis improved OAR sparing, and its impact was durable; however, fairly large dose differences still continue to exist. Additional work is needed to understand these variations and to minimize them. A national radiation oncology platform can be instrumental for developing and maintaining high-quality planning protocols.

Identifiants

pubmed: 31306734
pii: S0360-3016(19)33451-0
doi: 10.1016/j.ijrobp.2019.07.005
pii:
doi:

Types de publication

Comparative Study Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

514-524

Informations de copyright

Copyright © 2019 Elsevier Inc. All rights reserved.

Auteurs

Wilko F A R Verbakel (WFAR)

Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Radiation Oncology, Cancer Center Amsterdam, Amsterdam, the Netherlands. Electronic address: w.verbakel@vumc.nl.

Patricia A H Doornaert (PAH)

Department of Radiation Oncology, UMCU, Utrecht, the Netherlands.

Cornelis P J Raaijmakers (CPJ)

Department of Radiation Oncology, UMCU, Utrecht, the Netherlands.

Luc J Bos (LJ)

Department of Radiation Oncology, Northwest Clinics, Alkmaar, the Netherlands.

Marion Essers (M)

Department of Radiation Oncology, Verbeeten Institute, Tilburg, the Netherlands.

Jeroen B van de Kamer (JB)

Department of Radiation Oncology, the Netherlands Cancer Institute, Amsterdam, the Netherlands.

Max Dahele (M)

Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Radiation Oncology, Cancer Center Amsterdam, Amsterdam, the Netherlands.

Chris H J Terhaard (CHJ)

Department of Radiation Oncology, UMCU, Utrecht, the Netherlands.

Johannes H A M Kaanders (JHAM)

Department of Radiation Oncology, Radboud University Medical Center, Nijmegen, the Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH